SUN-626 Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus in a Seer-Medicare Cohort

por Thapi, Sahityasri, Baeg, Kiwoon, Kim, Michelle K, Gallagher, Emily Jane
Publicado 2020

Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis

por Rustgi, Sheila D., Oh, Aaron, Yang, Jeong Yun, Kang, Dasol, Wolin, Edward, Kong, Chung Y., Hur, Chin, Kim, Michelle K.
Publicado 2021

Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare ana...

por Ni, Katherine, Yang, Jeong Yun, Baeg, Kiwoon, Leiter, Amanda C., Mhango, Grace, Gallagher, Emily J., Wisnivesky, Juan P., Kim, Michelle K.
Publicado 2021

Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancer

por Rustgi, Sheila D, Amin, Sunil P, Kim, Michelle K, Nagula, Satish, Kumta, Nikhil A, DiMaio, Christopher J, Boffetta, Paolo, Lucas, Aimee L
Publicado 2019